Literature DB >> 7847181

Protective effects of papaverine salicylate in mouse ear dermatitis and PAF-induced rat paw oedema.

E de Bernardis1, G Leonardi, A Caruso, V M Cutuli, M Amico-Roxas.   

Abstract

Papaverine salicylate (MR-800) has been tested as a topical antiinflammatory agent in several models of skin inflammation in rodents, such as mouse ear dermatitis induced by croton oil, cantharidin or zymosan, and rat paw oedema induced by PAF. MR-800 exerted a dose-dependent inhibitory activity in all assays, when equimolar doses of sodium salicylate or papaverine were less effective, suggesting the existence of a favourable synergism between salicylate and papaverine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7847181     DOI: 10.1007/bf02014296

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  24 in total

1.  Generation of terminal complement complexes in psoriatic lesional skin.

Authors:  H Takematsu; H Tagami
Journal:  Dermatology       Date:  1992       Impact factor: 5.366

Review 2.  Inflammatory mediators in the skin.

Authors:  R D Camp; M W Greaves
Journal:  Br Med Bull       Date:  1987-04       Impact factor: 4.291

3.  Structural identification of platelet activating factor in psoriatic scale.

Authors:  A I Mallet; F M Cunningham
Journal:  Biochem Biophys Res Commun       Date:  1985-01-16       Impact factor: 3.575

4.  Analysis of cysteinyl leukotrienes and leukotriene B4 by gas chromatography-(tandem) mass spectrometry.

Authors:  D Tsikas; J Fauler; J C Frölich
Journal:  Eicosanoids       Date:  1992

Review 5.  Leukotriene B4 and platelet-activating factor in human skin.

Authors:  L Michel; L Dubertret
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

6.  Cantharidin-binding protein: identification as protein phosphatase 2A.

Authors:  Y M Li; J E Casida
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

7.  Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2A.

Authors:  R E Honkanen
Journal:  FEBS Lett       Date:  1993-09-20       Impact factor: 4.124

8.  Modulation by glycyrrhetinic acid derivatives of TPA-induced mouse ear oedema.

Authors:  H Inoue; T Mori; S Shibata; Y Koshihara
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

9.  Pharmacological modulation of Paf-induced rat pleurisy and its role in inflammation by zymosan.

Authors:  M A Martins; P M Silva; H C Faria Neto; P T Bozza; P M Dias; M C Lima; R S Cordeiro; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

10.  Quantification of chemotactic peptides (C5a anaphylatoxin and IL-8) in psoriatic lesional skin.

Authors:  H Takematsu; H Tagami
Journal:  Arch Dermatol       Date:  1993-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.